Results: The HbA1c level was significantly higher in the group with LVDD (6.96±1.23 vs. 9.00±2.19, p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objectives: This study aimed to investigate the relationship between hemoglobin A1c (HbA1c) levels, which is a good marker for determining glycemic levels, and left ventricular diastolic dysfunction (LVDD) in the type 2 diabetes mellitus (DM) patient population.
📊
Key Findings & Data:Patients and methods: This retrospective study was conducted with 116 type 2 DM patients (62 males, 54 females; mean age: 58.4±9.5 years; range, 18 to 65 years) between July 2019 and November 2021.
💡
Conclusion & Impact:Results: The HbA1c level was significantly higher in the group with LVDD (6.96±1.23 vs. 9.00±2.19, p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters
Abstract
Objectives: This study aimed to investigate the relationship between hemoglobin A1c (HbA1c) levels, which is a good marker for determining glycemic levels, and left ventricular diastolic dysfunction (LVDD) in the type 2 diabetes mellitus (DM) patient population. Patients and methods: This retrospective study was conducted with 116 type 2 DM patients (62 males, 54 females; mean age: 58.4±9.5 years; range, 18 to 65 years) between July 2019 and November 2021. The patients were divided into two groups as those without LVDD (n=55, Group 1) and those with LVDD (n=61, Group 2). Early to late diastolic transmural flow velocity (E/A) ratio, the mean ratio (E/e') of mitral inflow (E) and mitral annular (e'), HbA1c levels, other hemogram and biochemical parameters, and demographic data were recorded. Results: The HbA1c level was significantly higher in the group with LVDD (6.96±1.23 vs. 9.00±2.19, p
🔖
Cite This Article
GÜZEL, T., ŞENÖZ, O., KIŞ, M. (2022). The relationship between left ventricular diastolic dysfunction and hemoglobin A1c levels in the type 2 diabetes mellitus patient population. Cardiovascular surgery and interventions, Cilt: 9 - Sayı: 2, 97–103. https://ajindex.com/articles/470973
Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015;373:2117-28
Galderisi M. Diastolic dysfunction and diabetic cardiomyopathy: Evaluation by Doppler echocardiography. J Am Coll Cardiol 2006;48:1548-51
Schannwell CM, Schneppenheim M, Perings S, Plehn G, Strauer BE. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 2002;98:33-9
Yan D, Luo X, Li Y, Liu W, Deng J, Zheng N, et al. Effects of advanced glycation end products on calcium handling in cardiomyocytes. Cardiology 2014;129:75-83
Keser BN, Kaya F, Sandal V, Kırman ÜN, Tutal MR, Kocaaslan C, et al. Hemoglobin A1c levels do not predict primary arteriovenous fistula failure in hemodialysis patients. Cardiovasc Surg Int 2021;8:139-44
Özgök A, Ulus AT, Karadeniz Ü, Demir A, Kazancı D, Özyalçın S, et al. Does uncontrolled diabetes mellitus affect cerebral hemodynamics in heart surgery? Turk Gogus Kalp Dama 2020;28:84-91
Hassan Ayman KM, Abdallah Mahmoud A, Abdel- Mageed Eman A, Sayed Marwa, Soliman Mona M, Kishk Yehia T. Correlation between left ventricular diastolic dysfunction and dyslipidaemia in asymptomatic patients with new-onset type 2 diabetes mellitus. Egypt J Intern Med 2021;33:8
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.e14
American Diabetes Association
Classification and diagnosis of diabetes. Diabetes Care 2017;40(Suppl 1):S11-S24
Nagueh SF, Smiseth OA, Appleton CP, Byrd BF 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: An update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2016;29:277-314
Skrtic S, Cabrera C, Olsson M, Schnecke V, Lind M. Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes. Heart 2017;103:353-8
Yokota S, Tanaka H, Mochizuki Y, Soga F, Yamashita K, Tanaka Y, et al. Association of glycemic variability with left ventricular diastolic function in type 2 diabetes mellitus. Cardiovasc